• FDA approves botox for spasticity

News & Views

FDA approves botox for spasticity

Mar 12 2010

Botox can now be used as a treatment for people suffering from spasticity following US Food and Drug Administration (FDA) approval.

Individuals who have tremors in their elbow, wrist and fingers could benefit from the decision, with the condition prevalent in those who have multiple sclerosis, brain injuries or have had a stroke.

Temporarily blocking signals between the nerves and muscles, botox is able to paralyse spastic limbs for a short-term period.

Director of the neurology products division of the FDA's centre for drug evaluation and research Russell Katz said it could help patients to cope with the condition more easily.

"Muscles affected by spasticity have increased stiffness and tightness, which may lead to pain, difficulties with hygiene and other activities of daily living and may affect how a patient looks," he remarked.

According to the Multiple Sclerosis International Federation, more than two million people have the disease worldwide, with weak and unsteady limbs a common symptom.

Digital Edition

Lab Asia 31.1 - February 2024

February 2024

In This Edition Chromatography Articles - Comparing techniques for flow rate measurement in Liquid Chromatography Mass Spectrometry & Spectroscopy Articles - APGC: A Better Future with...

View all digital editions


SIAF Guangzhou

Mar 04 2024 Guanghzou, China

China Lab 2024

Mar 05 2024 Guangzhou, China

Laborama 2024

Mar 14 2024 Brussels, Belgium

MSACL 2024

Mar 17 2024 Monterey, CA, USA

ACS National Meeting & Expo, Spring 2024

Mar 17 2024 New Orleans, LA, USA

View all events